Read Financial Articles on Day Trading, Investment, Stock Market, NIFTY, BSE, NSE, Mutual Fund, Commodities and ETF
Share Gyan launches new website for COMMODITY TIPS. Register for free trial @ CommodityGyan.in now!


News Tagged as ‘Glenmark’

Closing Note: Sensex soars at end

Friday, May 29, 2009 3:58 pm No Comments

Domestic markets concluded the week in the positive zone as bulls had an impressive assembly on Dalal Street.

By ShareGyan.com NewsDesk Tags: , , , , , , , , , , , , , , , , , , , , , ,

Closing Note: Sensex on a high

Thursday, May 28, 2009 4:00 pm No Comments

The Sensex rushed 186 points to end at 14,296 after reaching an up of 14,377 and a down of 14,078. The index had hit at 14,115 opposed to the last end of 14,109.

By ShareGyan.com NewsDesk Tags: , , , , , , , , , , , , , , , , , , , , , , , , , ,

Glenmark Pharmaceuticals swings down

Monday, April 27, 2009 2:40 pm No Comments

Glenmark Pharmaceuticals presently trades at Rs.196.05, which is lower by 0.95 points from its last close of Rs.197 on the Sensex.

By ShareGyan.com NewsDesk Tags: , , , ,

Glenmark faces low trades

Tuesday, January 27, 2009 3:20 pm No Comments

Glenmark Pharmaceuticals presently trades at Rs.196.60, lower by 6.20 points from its earlier ending of Rs.202.80 on the Sensex.

By ShareGyan.com NewsDesk Tags: , , , ,

Glenmark Pharma leads the gainers on BSE

Wednesday, January 14, 2009 2:30 pm No Comments

Glenmark Pharmaceuticals presently trades at Rs 248 .75 up by 27.30 points or 12.33% from its previous closing of Rs 221.45 on the BSE.

By ShareGyan.com NewsDesk Tags: , , , ,
  • Page 2 of 2
  • <
  • 1
  • 2

Copyright © 2009 ShareGyan.com. All rights reserved.

Disclaimer: Trading or investing in stocks & commodities is a high risk activity. Any action you choose to take in the markets is totally your own responsibility. ShareGyan.com will not be liable for any, direct or indirect, consequential or incidental damages or loss arising out of the use of this information.

Disclosure: The information on this website is neither an offer to sell nor solicitation to buy any of the securities mentioned herein. The writers may or may not be trading in the securities mentioned.